11h
Onlymyhealth on MSNRenogrit: Patanjali’s Ayurvedic Breakthrough Recognised Among Top 100 Research Papers, Becomes A Milestone For Ayurvedic ScienceRenogrit Patanjali’s herbal formulation is featured among the top 100 research papers of 2024 in Scientific Reports Here’s ...
3d
ABP News on MSNAncient Solutions For Modern Lifestyles: How Patanjali Ayurved Is Taking Care Of Your HealthPatanjali Ayurveda claims that its products contain natural ingredients such as Ashwagandha, Shatavari, Triphala and Tulsi, ...
India's insurance sector is undergoing significant changes with policy shifts and new alliances. Allianz SE has ended its JV ...
5d
ABP News on MSNKidney Ailment Medicine 'Renogrit' Features On International Research List, Patanjali Calls It 'Historic Achievement'Patanjali's Acharya Balkrishna claims Renogrit's kidney treatment success is a major step towards global scientific recognition of Ayurveda.
4don MSN
The research paper on herbal formulation Renogrit by Patanjali has been featured among the top 100 research papers of 2024 in the “Scientific Reports” journal of prestigious “Nature Portfolio” ...
Haridwar: Inspired by Yog Rishi Swami Ramdev and evidence-based Ayurvedic medicine research conducted by scientists of ...
1d
Newspoint on MSNPatanjali is helping the farmers of the country, this is how the agriculture sector of the country is changing..Patanjali Ayurveda is one of India's leading names in natural and herbal products. In recent times, Patanjali has inaugurated ...
National Bank for Agriculture and Rural Development (NABARD) organised a programme under which a one day visit for the ...
India's tech start-ups raised $2.5 billion in Q1 2025, with Auto Tech, Enterprise Applications, and Retail leading sectors.
1don MSN
Other notable takeaways from the Tracxn report were the increase in funding for late-stage startups both sequentially and ...
Patanjali’s research paper on the herbal formulation Renogrit has been recognized among the top 100 research papers of 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results